Results 61 to 70 of about 1,128 (134)
Emergence of Meningitis Caused by Nonvaccine Serotypes of Pneumococcus in Rural United States
Case Reports in Pediatrics, 2020 Pneumococcal conjugate vaccines have decreased the rates of invasive pneumococcal disease (IPD) in children. Since vaccine introduction, however, rates of infection due to nonvaccine Streptococcus pneumoniae serotypes have increased.
Jessie Marks +3 more
doaj +1 more source
Педиатрическая фармакология, 2014 Compulsory use of the 7-valent pneumococcal conjugate vaccine in the framework of national pediatric immunization schedules of the developed countries resulted in significant decrease in the prevalence of the pneumococcal infections induced by the ...
M. V. Fedoseenko +6 more
doaj +1 more source
Safety profile of pneumococcal conjugate vaccines: systematic review of pre- and post-licensure data
Bulletin of the World Health OrganizationA 7-valent pneumococcal polysaccharide-protein conjugate vaccine (PCV7) was licensed in the United States of America in 2000, but no comprehensive postmarketing review of safety has been carried out. We conducted a systematic review of the safety of PCV7
Frank DeStefano +2 more
doaj +1 more source
Pneumococcal conjugate vaccines: a review of ethical considerations and socio-economic impact
Revista Habanera de Ciencias Médicas, 2021 Introduction: Pneumococcal conjugate vaccines (PCVs) have been available in many parts of the world for more than 15 years and are effective in preventing pneumococcal diseases in children.
Xu Han +2 more
doaj
Pneumonia, 2013 Pneumonia in childhood is endemic in large parts of the world and in particular, in developing countries, as well as in many indigenous communities within developed nations.
Diana C Otczyk, Allan W Cripps
doaj +1 more source
Pneumococcal conjugate vaccine--a health priority.
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2008 Pneumonia is a major cause of childhood mortality and morbidity. Streptococcus pneumoniae is the most important bacterial pathogen causing pneumonia in children. The HIV epidemic has increased the burden and severity of childhood pneumococcal pneumonia and invasive disease fortyfold.
Zar, Heather J, Madhi, Shabir A
openaire +3 more sources
Pneumococcal conjugate vaccine use in adults
Expert Review of Vaccines, 2015 Streptococcus pneumoniae is a leading cause of illness and death in adults. A polysaccharide vaccine has been available for over 30 years, but despite significant use, the public health impact of this vaccine has been limited. The 13-valent pneumococcal conjugate vaccine (PCV13) has been licensed by the US Food and Drug Administration and other ...
Raul E. Isturiz +6 more
openaire +2 more sources
Recommendations and guidance for pneumococcal vaccination for adults in Taiwan
Journal of Microbiology, Immunology and InfectionStreptococcus pneumoniae remains a global health concern, causing diseases from sinusitis, otitis media, to invasive pneumococcal diseases (IPD), such as bacteremia, bacteremic pneumonia, empyema, and meningitis.
I-Fan Lin +26 more
doaj +1 more source
Approaches to vaccination of adults against pneumococcal disease in different countries of the world
Журнал инфектологииVarious pneumococcal vaccines are available worldwide, differing in the range of serotypes coverage and type of vaccine, which determine different mechanisms of action and postvaccinal immunity. Vaccination against pneumococcal infection is recommended
A. S. Korovkin +2 more
doaj +1 more source
Health Technology AssessmentBackground Vaccination of infants with pneumococcal conjugate vaccines is recommended by the World Health Organization. Evidence is mixed regarding the differences in immunogenicity and efficacy of the different pneumococcal vaccines.
Shuo Feng +13 more
doaj +1 more source